Molecular Mechanisms of Cardiac Fibrosis: A Pathologist's Perspective

Area of Science:

• Pathology
• Cardiovascular Biology
• Molecular Medicine

Background:

• Cardiac fibrosis is a common endpoint for various heart conditions, leading to structural changes, diastolic dysfunction, and heart failure.
• Pathologically, fibrotic remodeling manifests as interstitial, perivascular, and replacement patterns, reflecting underlying cellular and molecular processes.
• Fibroblast activation into myofibroblasts is central, driven by profibrotic pathways like TGF-β/SMAD, Wnt/β-catenin, and Hippo/YAP/TAZ.

Purpose of the Study:

• To integrate molecular signaling mechanisms with morphologic evidence of cardiac fibrosis.
• To highlight the pathologist's role in linking molecular insights to diagnostic interpretation.
• To provide a foundation for developing novel antifibrotic therapies.

Main Methods:

• Review of molecular signaling cascades (e.g., TGF-β, Wnt, Hippo pathways) involved in fibroblast activation.
• Analysis of neurohumoral mediators (angiotensin II, aldosterone) and epigenetic modulators (n-c RNAs).
• Correlation of molecular events with histopathological findings (collagen deposition, α-SMA expression, ECM cross-linking) using immunohistochemistry and digital morphometry.

Main Results:

• Profibrotic signaling pathways (TGF-β/SMAD, Wnt/β-catenin, Hippo/YAP/TAZ) drive cardiac fibroblast activation.
• Neurohumoral factors and epigenetic regulators amplify extracellular matrix synthesis and perpetuate fibrosis.
• Histopathological features like collagen deposition and α-SMA expression are direct correlates of these molecular mechanisms.

Conclusions:

• Cardiac fibrosis results from complex molecular signaling driving fibroblast activation and matrix remodeling.
• Pathologists play a vital role in interpreting fibrotic changes by connecting molecular mechanisms to diagnostic findings.
• Targeting key molecular nodes in fibroblast activation and matrix remodeling offers potential for new antifibrotic treatments.